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Abstract Screening of the Helicobacter pylori genomic library
with sera from infected humans and from immunized rabbits
resulted in identi¢cation of the 25 kDa protein cell envelope
(HppA) which exhibits acid phosphatase activity. Enzyme activ-
ity was demonstrated by speci¢c enzymatic assays with whole-
cell protein preparations of H. pylori strain N6 and from Es-
cherichia coli carrying the hppA gene (pUWM192). HppA
showed optimum activity at pH 5.6 and was resistant to inhibi-
tion by EDTA. Bioinformatics analysis and site-directed muta-
genesis of two putative active site residues (D73 and D192)
provide further insight into the sequence^structure^function re-
lationships of HppA as a member of the DDDD phosphohydro-
lase superfamily. 2 2002 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
Helicobacter pylori is a curved, microaerophilic, Gram-neg-
ative bacterium that persistently colonizes the gastric epithe-
lium of humans and other primates [1]. The infection persists
for decades, resulting in the development of gastric mucosal
in£ammation, and is a risk factor for the development of
peptic ulcer disease and gastric adenocarcinoma. Treatment
of H. pylori involves expensive combinations of various med-
icines (antibiotics, proton pomp inhibitors) and is not always
e¡ective [2].
In a previous study we reported the construction and
screening of a H. pylori expression library in order to identify
potential candidates for subunit vaccine antigens [3]. A num-
ber of 114 positive clones were isolated. One of them was
predicted to encode a 25 kDa membrane protein of unknown
function (92% DNA sequence identity with hypothetical pro-
tein HP1285 from H. pylori strain 26695). 40% sequence sim-
ilarity between this protein and acid phosphatase LppC from
Streptococcus equisimilis [4] prompted us to explore the pos-
sibility that this novel antigenic protein is endowed with phos-
phatase activity.
Many bacterial phosphatases function as scavengers of or-
ganic phosphoesters [5,6] but some of them are also involved
in signal transduction and microbial pathogenesis [7,8]. Bac-
terial non-speci¢c acid phosphohydrolases (NSAPs) are se-
creted enzymes, produced as soluble proteins associated with
the periplasmic space or as membrane-bound lipoproteins.
They generally dephosphorylate a broad array of substrates
and have optimal catalytic activity at an acidic to neutral pH.
Three classes of NSAP, designated A, B and C, have been
proposed based on clustering of amino acid sequences, with
HP1285 (ortholog of the protein analyzed in this work)
grouped with class C [9]. The authors suggest that bacterial
NSAPs of classes B and C, as well as related plant phospha-
tases, belong to a family of enzymes dubbed DDDD phos-
phohydrolases.
This family was shown to belong to a large superfamily of
HAD hydrolases, which also includes P-type ATPases and
haloacid dehalogenases [10].
2. Materials and methods
2.1. Bacteria and growth conditions
H. pylori strain N6, kindly provided by Dr. Agnes Labigne (Institut
Pasteur) was grown under microaerobic conditions at 37‡C on Blood
Agar Base No2 (Sigma) containing 10% horse blood. The media for
H. pylori mutants contained kanamycin (25 Wg/ml). Escherichia coli
strains DH5 (Gibco BRL) and M15 (Qiagen) were grown at 37‡C on
LB agar or in broth. E. coli transformants were grown in the presence
of the appropriate antibiotic (ampicillin 100 Wg/ml or kanamycin 25
Wg/ml).
2.2. Recombinant DNA techniques
Procedures for plasmid DNA isolation and DNA analysis (diges-
tion with restriction enzymes, T4 ligase ligation, Southern blots), aga-
rose gel electrophoresis and transformation of E. coli competent cells
were carried out as described by Sambrook [11]. DNA sequencing was
performed on an ABI Prism 377 automated DNA sequencer (Perkin-
Elmer).
The nucleotide sequence of the hppA gene has been deposited in the
EMBL Nucleotide Sequence Database under accession no. AJ428848.
An E. coli strain that overproduces HppA was engineered by clon-
ing the hppA coding region into pQE70 under the control of an in-
ducible lacZ gene promoter. The 654 bp DNA fragment was PCR-
ampli¢ed from pUWM192 with the oligonucleotide pair: 5P-GCAT-
GCGTATGTTAAATGCCAAAGAAT and 5P-GGATCCATCTTC-
CCATGTGCCATA containing the recognition sequences (under-
lined) for SphI and BamHI. The resulting PCR product was cloned
into pQE70 (Qiagen). (His)6HppA recombinant protein was prepared
from IPTG-induced E. coli M15(pREP4, pQE70/hppA) culture and
puri¢ed by Ni-NTA a⁄nity chromatography as described in the man-
ufacturer’s protocol (Qiagen). Puri¢ed (His)6HppA was used for rab-
bit immunization.
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Gene replacement was used to construct the H. pylori hppA isogenic
mutant. Two internal fragments of the gene were ampli¢ed by PCR
and cloned into the H. pylori non-replicable vector pBluescript II SK
with an inactivated ClaI site in MCS. The following oligonucleotides
were used: 5P-CCCGGGTCTCGCCCATAACAAGA-3P, 5P-ATCG-
ATCCCCCAAGTGAGCGAAGAAT-3P, 5P-ATCGATGCGTGCG-
GTTAGAAATGTA-3P, 5P-CTTCCCATGTGCCATAAAGAG-3P.
Primers contained SmaI and ClaI restriction site overhangs (under-
lined) to facilitate cloning of the ampli¢ed DNA fragments in the
appropriate orientation. A ClaI-ended kanamycin-resistant cassette
carrying the Campylobacter jejuni aph(3P)-III gene (1.4 kb) was in-
serted into unique ClaI sites among cloned PCR fragments. H. pylori
N6 strain, naturally competent for genetic transformation, was used
for generation of isogenic H. pylori hppA mutants. The obtained ka-
namycin-resistant transformants were screened by hybridization using
cloning vector DNA as a probe to con¢rm that no vector DNA was
integrated into the chromosome via single cross over. Moreover, no
25 kDa protein was detected in the cell extract obtained from H. pylori
hppA isogenic mutant (data not shown). The lack of hppA gene prod-
uct is not lethal for bacterial cells. Mutant showed typical Helico-
bacter morphology and no alterations of growth rate.
Point mutations were generated using the Quick-Change site-di-
rected mutagenesis kit following the procedures recommended by
the supplier (Stratagene). Plasmid pUWM192 was used as a template
for PCR-mediated mutagenesis and the following mutagenic oligonu-
cleotide primers (reverse complements are not shown): HP1285 D73A
GCCAGCTGTCATTTTGGCTTTAGATGAAACCG; HP1285
D192A GTGGGCGATACTTTGCATGCTTTTGACGCACTTTTT-
GC.
Mismatches are underlined. Plasmids, pUWM314 containing hppA
with D72A mutation and pUWM315 with the D192A mutation, were
transformed into E. coli DH5K. The presence of the desired mutations
was con¢rmed by DNA sequencing.
2.3. Western blot analysis
SDS^PAGE was carried out as described by Laemmli [12]. Western
blot detection of HppA was performed using a 1:750 dilution of anti-
HppA rabbit antibodies and goat anti-rabbit IgG conjugated to alka-
line phosphatase (Sigma).
2.4. Preparation of cellular fractions
Cellular fractions were prepared by the method described by Blaser
et al. [13]. The outer membrane fraction was isolated from cell enve-
lopes by the sodium lauroyl sarcosine procedure of Filip [14]. The
periplasmic fraction was prepared by the osmotic shock procedure
of Ames [15].
2.5. Phosphatase assays
Whole-cell protein preparations were examined for phosphatase
activity with disodium p-nitrophenol phosphate (pNPP, Sigma) as a
substrate [16]. Brie£y, the 0.5 ml assay mixture contained 0.1 M so-
dium acetate, pH 5.6, 5 mM pNPP and varying amounts of sample.
Incubation was at 37‡C for 30 min. The reaction was stopped by
addition of 0.5 ml 0.2 M NaOH. Concentration of the released
p-nitrophenol (pNP) was measured at 415 nm in the linear range of
the calibration curve. Protein concentrations were determined by the
bicinchoninic acid method (Sigma) with bovine serum albumin as a
standard. The phosphatase inhibition test was accomplished in stan-
dard reaction mixture in the presence of 15 mM EDTA. Determina-
tion of the pH optimum of HppA enzyme was performed with pNPP
as the substrate in 0.1 M bu¡ers: sodium acetate bu¡er (pH 4^6),
Tris^HCl bu¡er (pH 7^9) and glycine/NaOH bu¡er (pH 10).
2.6. Protein sequence analysis and structure prediction
The PSI-BLAST algorithm [17] was used to search the non-redun-
dant version of current sequence databases and the publicly available
complete and incomplete genome sequences at the NCBI website
(http://www.ncbi.nlm.nih.gov) using the HppA sequence as a query.
The resulting multiple sequence alignment was re¢ned using CLUS-
TALX [18]. Protein structure prediction was done using the Meta-
Server available at http://bioinfo.pl/meta/, which combines several sec-
ondary structure prediction and fold recognition methods [19]. The
fold recognition methods compare the query sequence with a library
of structures (templates) and return 10 alignments that scored best
according to the implemented criterion of compatibility. The results
are evaluated by the Pcons server [20], which compares the models
and the associated scores and produces a ranking of potential best
alignments with related proteins, whose structures are known. The
consensus alignment provided by MetaServer served as a basis for
homology modeling carried out using the SWISS-MODEL/PRO-
MOD II server [21]. Protein structure evaluation was carried out using
the Verify3D program [22], suggesting that the stereochemistry and
energetic parameters of the model were acceptable.
3. Results and discussion
Our earlier studies have described the construction and
screening of H. pylori expression libraries. When antiserum
raised in rabbits exposed to formalin-killed bacterial cells
and when human antisera from infected patients were used
to screen H. pylori genomic libraries several immunopositive
clones were identi¢ed [3]. One of them, containing a 1082 bp
H. pylori DNA fragment inserted into the EcoRI site of
pBluescript II SK, produced an immunopositive protein
with an apparent Mr of 25 000, as determined by SDS^
PAGE and Western blot. Sequence analysis identi¢ed a com-
plete 738 bp gene encoding a putative protein with a calcu-
lated molecular mass of 28 kDa. Based on the results of the
analysis reported herein, we designated his protein HppA
(H. pylori phosphohydrolase). The hppA gene expression in
E. coli is probably driven from its own promoter, since clon-
ing of the above-mentioned fragment in the opposite orienta-
tion resulted in a product showing cross-reactivity with the
same antiserum. To determine subcellular localization of
HppA in H. pylori N6 and E. coli/pUWM192, cell fractiona-
tion was carried out. Western blots of H. pylori proteins iso-
Fig. 1. Western blot detection of HppA protein in cell fractions of E. coli/pUWM192 (A) and H. pylori N6 (B). The results were obtained
from SDS^12% PAGE of whole-cell extract (lane 1), outer membrane fraction (lane 2), cell envelope fraction (lane 3), periplasmic fraction
(lane 4) and whole-cell extract without periplasmic proteins (lane 5).
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lated from di¡erent cell compartments probed with rabbit
antiserum to recombinant (His)6HppA protein showed that
HppA was recovered in the sarcosyl-insoluble fraction. In
contrast, analysis of the E. coli/pUWM192 proteins revealed
the presence of HppA in the crude cell envelope fraction when
extracted by sarcosyl treatment (Fig. 1). No HppA was de-
tected in the outer membrane fraction of E. coli/pUWM192.
The sequence of HppA was analyzed using the Structure
Prediction MetaServer [19], providing compelling evidence
that this protein is remotely related to structurally character-
ized members of the DDDD superfamily (comprehensive
results are available online at the following URL: http://
bioinfo.pl/meta/target.pl?id= 5774). Most of the individual
fold recognition servers detected similarity between HppA
and the DDDD fold (FSSP: 147.2.3; SCOP: e.21.1 http://
scop.mrc-lmb.cam.ac.uk/scop/) and the consensus server eval-
uated this prediction as highly con¢dent. In order to charac-
terize the sequence^function relationships of HppA at the
structural level, we attempted to build and evaluate a three-
dimensional model. The phosphonoacetaldehyde hydrolase
structure [23] was used as the template, since it was suggested
as the top match by the consensus server (see Section 2 and
the URL given above). The quality of the theoretical model of
HppA was evaluated as reasonable (average Verify3D
score = 0.29), hence we used it to identify the putative catalytic
site (Fig. 2).
To validate the bioinformatics-based assignment of HppA
to the HAD superfamily and speci¢cally to the family of non-
speci¢c phosphatases, we analyzed the enzymatic activity of
the protein. To achieve this, the speci¢c phosphomonoesterase
activity of whole-cell fractions from E. coli/pUWM192,
H. pylori N6 and the isogenic hppA insertion mutant were
determined. As shown in Table 1, the cells of H. pylori N6/
hppA: :Km possessed enzyme activity at approximately 48%
of the activity level of wild-type cells. A greater di¡erence was
observed between two examined E. coli strains. E. coli/
pUWM192 was almost four times more active than the
hppA-free control strain.
In order to validate the structural model and provide fur-
ther insight into the function of HppA at the molecular level,
we carried out alanine mutagenesis of predicted catalytic/met-
al binding residues D73 and D192.
Whole-cell extracts from cultures of D73A and D192A mu-
tants were analyzed for speci¢c phosphatase activity (Table 1).
Mutants possessed activity at approximately the same level as
negative control (E. coli/pBluescript II KS). Western blot
analysis using speci¢c anti-HppA antibodies showed that
E. coli containing wild-type and mutated versions of the
hppA gene produced comparable amounts of HppA protein
(data not shown). Thus, aspartic residues in positions D73
and D192 of HppA protein are required for phosphatase ac-
tivity, thereby validating the structural model.
The whole-cell protein preparations from E. coli/pUWM192
were used as a source of HppA phosphatase to study some
functional properties of the enzyme. When pNPP was used as
substrate, the HppA enzyme showed a pH optimum around
5.5, retaining more than 50% of the maximal activity in the
pH range from 4 to 7 (Fig. 3). Enzyme activity was not in-
hibited by 15 mM EDTA (data not shown).
In this study we provided evidence for the fact that in ac-
cordance with in silico conducted analyses, the hppA gene
product exhibits acid phosphatase activity and is a class C
NSAP. Mutagenesis of the predicted catalytic residues, com-
mon with other phosphatases from the NSAP family, abol-
ished the enzymatic activity of HppA.
Enzyme activity elaborated by E. coli/pUWM192 exceeded
Fig. 2. The predicted three-dimensional structure of HppA and the
architecture of the putative phosphatase active site. The putative
catalytic/binding residues are shown in ball-and-stick representation
and labeled; the metal ion serving as a cofactor is shown as a
sphere.
Table 1
Speci¢c acid phosphatase activity of H. pylori and E. coli whole
cells as measured by the release of pNP from pNPP
Strain pNP released (Wmol/min/mg protein)
H. pylori N6 0.92V0.33
H. pylori N6/hppA: :Km 0.49V0.10
E. coli/pUWM192 1.92V0.42
E. coli/pBluescript II SK 0.44V0.13
E. coli/pUWM314 0.12V0.02
E. coli/pUWM315 0.13V0.05
Average activity of ¢ve independent samples for each clone is
shown with standard deviation.
Fig. 3. pNPP hydrolysis activity of E. coli/pUWM192 whole-cell
protein extracts at di¡erent pH values.
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the activity of the control strain only about four times,
although the gene was cloned into a high copy number vector
(pBluescript II KS), whereas the S. equisimilis lppC gene
(cloned into pACYC184) product was 14.8 times more active
than the lppC-free control [4]. Both analyzed genes were ex-
pressed in E. coli from their authentic promoters. The diver-
gence of these results may re£ect a di¡erence in a⁄nity of the
E. coli RNA polymerase for the individual gene promoters.
Even though the knowledge concerning H. pylori promoter
consensus sequences is incomplete, it is documented that not
all H. pylori promoters are e⁄ciently recognized by E. coli
transcription machinery [24]. Consistent with that, we were
unable to demonstrate phosphatase activity of E. coli/
pUWM192 by zymographic techniques (data not shown).
The hppA coding sequence contains two putative ATG start
codons located at a distance of 45 nucleotides. Although the
sequence of the HppA N-terminus has not been determined,
membrane localization of the protein strongly suggests that
the ¢rst ATG codon is recognized as a translation start.
The production of the cytoplasm-located HppA seems to be
toxic for E. coli cells. Induction of the recombinant gene ex-
pression by IPTG was found to lead to rapid growth cessation
(data not shown).
The present results indicate that in H. pylori HppA protein
is localized to the outer membrane. Computational analysis of
the signal peptide revealed that the putative peptidase cleav-
age site (LNAKsAC) di¡ers strongly from the consensus se-
quence of the lipoprotein signal cleavage site (LV(A,G)sC)
[25]. One potential reason for this discrepancy could be di¡er-
ential localization of HppA of H. pylori and E. coli. On the
other hand, numerous attempts at H. pylori cell fractionation
revealed problems with obtaining clear fractions. Some pro-
teins which are cytoplasmic in other species may leak out of
the Helicobacter cell and become associated with the surface
[26,27]. Moreover, the inner and outer membranes of H. py-
lori interact tightly, preventing absolute separation of frac-
tions [28].
We also failed to overproduce HppA as a fusion with GST
or His tags added to the C-terminus of the mature protein.
Constructs were genetically correct as veri¢ed by DNA se-
quencing. In this case IPTG induction did not in£uence the
cell growth rate, nevertheless recombinant proteins were not
produced. The cloned hppA heterologous gene di¡ers mark-
edly in codon bias from that of E. coli. Codon usage in
H. pylori is characterized by a relative lack of heterogeneity
among genes, and in particular an absence of di¡erentiation
between highly expressed genes and others [29]. In contrast,
E. coli has a set of major codons that occur in highly ex-
pressed genes and a set of rare codons in genes expressed at
a low level [30]. Within the hppA gene, 15.5% of the amino
acids are encoded by codons used by E. coli at a frequency of
6 1%. Especially usage of the AGG/AGA, CUA, AUA,
CGA, CCC cluster of codons, which consist of almost 6%
of hppA codons and presence of lysine residues constitutes
13% of HppA, being three times as numerous as in average
E. coli proteins, could create a translation problem, and re-
duce the quantity and quality of synthesized protein [31].
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